Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $416.41 million as of September 16, 2024. Its market cap has increased by 356.36% in one year.

Market Cap

416.41M

Enterprise Value

419.67M

Revenue

66.45M

Ranking

n/a

PE Ratio

20.48

Stock Price

$0.39

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 416.41M, an increase of 4,248.86%. That is a compound annual growth rate of 15.51%.

Market Cap History

Date	Market Cap	% Change
Sep 13, 2024	384.69M	170.59%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	77.08M	25.51%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	17.85B
Telix Pharmaceuticals Limited	4.28B
Elekta AB (publ)	2.47B
Ryman Healthcare Limited	1.99B
Verano Holdings Corp.	1.14B
Vireo Growth Inc.	108.59M
Medexus Pharmaceuticals Inc.	49.44M

Market Cap Rankings